CPG:LSECompass Group PLC Analysis
Data as of 2026-05-24 - not real-time
$31.13
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Compass Group is trading comfortably above its 20‑day, 50‑day and 200‑day moving averages, underscoring a clear bullish bias. The recent surge in trading volume reinforces the strength of the upward move. Momentum indicators show the Relative Strength Index sitting in the upper half of its range, suggesting continued buying pressure without yet being overbought. The MACD histogram has turned negative and the signal line is bearish, hinting at a possible short‑term softening. Volatility remains elevated, reflecting the stock’s sensitivity to market swings. At current levels the market price sits well above the discounted cash‑flow based fair value, indicating a degree of overvaluation.
The company delivered a double‑digit revenue increase on a constant‑currency basis and lifted underlying operating profit, pointing to robust top‑line growth. Operating margins have improved, and management has raised its full‑year profit outlook, reinforcing earnings momentum. Strong operating cash flow and a healthy free cash flow cushion support the existing dividend payout. With a dividend yield that compares favorably to peers and a payout ratio below the critical threshold, the dividend appears sustainable. The business’s diversified geographic footprint mitigates concentration risk, though exposure to multiple currencies adds a modest layer of uncertainty. Overall, the blend of solid fundamentals and a resilient cash‑generation profile suggests the stock is well‑positioned for patient investors.
The company delivered a double‑digit revenue increase on a constant‑currency basis and lifted underlying operating profit, pointing to robust top‑line growth. Operating margins have improved, and management has raised its full‑year profit outlook, reinforcing earnings momentum. Strong operating cash flow and a healthy free cash flow cushion support the existing dividend payout. With a dividend yield that compares favorably to peers and a payout ratio below the critical threshold, the dividend appears sustainable. The business’s diversified geographic footprint mitigates concentration risk, though exposure to multiple currencies adds a modest layer of uncertainty. Overall, the blend of solid fundamentals and a resilient cash‑generation profile suggests the stock is well‑positioned for patient investors.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price above key moving averages
- Bearish MACD divergence
- Elevated volatility
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Strong revenue and margin expansion
- Raised profit outlook
- Sustainable dividend with solid cash flow
Long Term
> 3 yearsNeutral
Model confidence: 8/10
Key Factors
- Resilient, diversified business model
- Consistent dividend yield
- Robust free cash flow generation
Key Metrics & Analysis
Financial Health
Revenue Growth10.70%
Profit Margin4.16%
P/E Ratio26.2
ROE26.88%
ROA7.29%
Debt/Equity113.11
P/B Ratio6.9
Op. Cash Flow$3.6B
Free Cash Flow$2.0B
Technical Analysis
TrendBullish
RSI57.8
Support$27.78
Resistance$33.31
MA 20$30.43
MA 50$27.19
MA 200$24.85
MACDBearish
VolumeIncreasing
Fear & Greed Index91.61
Valuation
Fair Value$18.64
Target Price$38.28
Upside/Downside22.96%
GradeOvervalued
TypeGrowth
Dividend Yield2.20%
Risk Assessment
Beta1.03
Volatility35.59%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.